La vendita allo scoperto per BlackSky Technology dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di BlackSky Technology. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

BlackSky Technology (NYSE:BKSY) Azioni, Report sulle vendite allo scoperto

BlackSky Technology

BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

BlackSky Technology Inc. Class A Common Stock

BKSY

HYZN

MTRX

ORCL

Scopri i 5 titoli da seguire oggi, 9 settembre 2024, con Oracle, BlackSky, Mission Produce e altri nel mirino.

Pre-market: 5 titoli da monitorare oggi, 9 settembre 2024

BlackSky Technology Inc

BlackSky Technology Inc. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock

Biotech

Health Care

Contracts

General

AIMD

Ainos Signed A Memorandum Of Understanding With Taiwan Tanabe Seiyaku, A Subsidiary Of Mitsubishi Tanabe Pharma In Japan, To Promote Ainos' Sjögren's Syndrome Drug, Veldona

<p>Morgan Stanley  analyst Patrick Wood   downgrades Bausch &amp; Lomb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLCO#NYSE">BLCO</a>) from Overweight to Equal-Weight and announces $19 price target.</p>


Downgrades

Price Target

Analyst Ratings

BLCO

Morgan Stanley Downgrades Bausch & Lomb to Equal-Weight, Announces $19 Price Target

<ul>
<li>AWS will work with Orbital to utilize its proprietary AI platform to design, synthesize and test new technologies and advanced materials for data center-integrated carbon removal, chip cooling and water utilization. Orbital will pilot its integrated data center carbon removal technology by the end of 2025.</li>
<li>Developing new advanced materials has traditionally been a slow process of trial and error in the lab. Orbital replaces this with generative AI design, radically improving the speed and efficacy of materials discovery and new technology commercialization. Its first product is a carbon removal technology utilizing a proprietary active material. Since establishing its lab in the first quarter of 2024, Orbital has achieved a 10x improvement in its material's performance through the use of its AI platform - an order of magnitude faster than traditional development and breaking new ground in carbon removal efficacy.</li>
</ul>


Large Cap

AMZN

Orbital Materials And Amazon Web Services, An Amazon.Com Company, Have Entered Into A Multi-year Partnership To Use AI To Develop New Data Center Decarbonization And Efficiency Technologies

<p>Morgan Stanley  analyst Drew Ranieri   upgrades Stryker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYK#NYSE">SYK</a>) from Equal-Weight to Overweight and raises the price target from $370 to $445.</p>


Upgrades

Morgan Stanley Upgrades Stryker to Overweight, Raises Price Target to $445

ESPR

Esperion Has Filed New Drug Submissions To Health Canada For Nexletol And Nexlizet, Once-daily, Accessible, Oral Non-statin Medications That Reduce Low-density Lipoprotein Cholesterol And Cardiovascular Risk.

<p>Morgan Stanley  analyst Cecilia Furlong   upgrades Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) from Equal-Weight to Overweight and raises the price target from $522 to $650.</p>


ISRG

Morgan Stanley Upgrades Intuitive Surgical to Overweight, Raises Price Target to $650

Stock Split

Psychemedics Approved A 1-for-5,000 Reverse Stock Split Followed Immediately By A 5,000-for-1 Forward Stock Split, To Be Effective At 5:01 P.M. And 5:02 P.M., Eastern Time, Respectively, On Tuesday, December 3

<p>Morgan Stanley  analyst Patrick Wood   initiates coverage on PROCEPT BioRobotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRCT#NASDAQ">PRCT</a>) with a Overweight rating and announces Price Target of $105.</p>


Initiation

PRCT

Morgan Stanley Initiates Coverage On PROCEPT BioRobotics with Overweight Rating, Announces Price Target of $105

VEON

VEON Launched A Generative AI Lab By Kyivstar In Partnership With Amazon Web Services, This Initiative Will Help Ukrainian Enterprises Introduce AI Technologies To Enhance Business Processes And Contribute To The Country's Long-term Economic Recovery

HEPA

Hepion Pharmaceuticals Sent An Open Letter To Shareholders Urging Them To Vote For Hepion's Proposed Merger With Pharma Two B At The Company's Upcoming Special Meeting Of Stockholders On December 12

HOLX

Hologic Presented New Research Demonstrating The Performance Of Its Genius AI Detection 2.0 Software Across Diverse Patient Populations At The Scientific Assembly And Annual Meeting Of The Radiological Society Of North America

PLRZ

Polyrizon Signed Manufacturing Agreement With Eurofins CDMO Amatsiaquitaine For Supply Of Clinical Trial Material For Polyrizon's PL-14 Allergy Blocker, In Preparation For A Clinical Trial That Is Expected To Commence In 2025

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>Name</strong></th>
<th align="right"><strong>Price</strong></th>
<th align="right"><strong>Change ($)</strong></th>
<th align="right"><strong>Change (%)</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">223.4800</td>
<td align="right">1.180</td>
<td align="right">0.53</td>
<td>635</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">98.5882</td>
<td align="right">0.188</td>
<td align="right">0.19</td>
<td>1.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">94.9000</td>
<td align="right">0.120</td>
<td align="right">0.12</td>
<td>205</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">83.3199</td>
<td align="right">0.100</td>
<td align="right">0.12</td>
<td>1.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">95.5500</td>
<td align="right">0.020</td>
<td align="right">0.02</td>
<td>27.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">51.3500</td>
<td align="right">0.010</td>
<td align="right">0.01</td>
<td>52.7K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>Name</strong></th>
<th align="right"><strong>Price</strong></th>
<th align="right"><strong>Change ($)</strong></th>
<th align="right"><strong>Change (%)</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">233.33</td>
<td align="right">-0.40</td>
<td align="right">-0.18</td>
<td>18.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">44.96</td>
<td align="right">-0.04</td>
<td align="right">-0.09</td>
<td>824</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">82.92</td>
<td align="right">-0.01</td>
<td align="right">-0.02</td>
<td>26.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">147.40</td>
<td align="right">-0.01</td>
<td align="right">-0.01</td>
<td>2.3K</td>
</tr>
</tbody>
</table>
<p><a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alerts can help traders understand macro-level market trends. Traders often look for sector movers to provide high-level analysis on which sectors are over- or under-performing to make better investing decisions on exchange traded funds (ETFs) or individual tickers in those sectors. </p>
<p><em>To read more about sector movers, <a href="https://www.benzinga.com/movers">click here</a>.</em> </p>


Sector ETFs

Movers

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For December 2, 2024

<p>Loop Capital  analyst Chris Dankert   maintains Emerson Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) with a Buy and raises the price target from $130 to $155.</p>


Loop Capital Maintains Buy on Emerson Electric, Raises Price Target to $155

<p><strong>JPMorgan Chase &amp; Co</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) has been <a target="_blank" href="https://www.mas.gov.sg/regulation/enforcement/enforcement-actions/2024/mas-imposes-civil-penalty-on-jpmorgan" rel="noreferrer noopener">fined </a>S$2.4 million ($1.8 million) by the Monetary Authority of Singapore (MAS) for failing to prevent and detect misconduct by its relationship managers (RMs).</p>
<p>In 24 over-the-counter (OTC) bond transactions between November 2018 and September 2019, the RMs provided clients with inaccurate or incomplete disclosures, resulting in spreads exceeding agreed rates.</p>
<p>Investigations found that JPM's practice was to charge clients a spread over the interbank prices for OTC bond transactions. As the interbank prices were not available to clients, they had to rely on the RMs' representations regarding the interbank prices and spreads.&nbsp;</p>
<p>The bank failed to establish adequate controls to ensure adherence to pre-agreed spreads, leading to misrepresentation or omission of key pricing details in violation of sections 201(c) and 201(d) of the Securities and Futures Act (SFA).</p>
<p><strong>Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42253107/jpmorgan-tesla-settle-3-year-old-dispute-over-stock-warrants" rel="noreferrer noopener">JPMorgan, Tesla Settle 3-Year-Old Dispute Over Stock Warrants</a></strong></p>
<p>JPMorgan admitted liability under section 236C of the SFA, paid the MAS penalty, refunded overcharged fees to affected clients, and strengthened its pricing frameworks and internal controls. The bank is also conducting ongoing reviews of the RMs involved in the misconduct.</p>
<p><strong>Price Action:</strong> JPM shares closed lower by 0.03% at $249.72 on Friday.</p>
<p><em>Photo: Courtesy of Satur via Shutterstock</em></p>


Equities

Government

Regulations

JPMorgan Fined ~$1.8M In Singapore Over Misconduct By Its Relationship Managers: Details

<p>Loop Capital  analyst Alan Gould   maintains Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) with a Buy and raises the price target from $120 to $180.</p>


RDDT

Loop Capital Maintains Buy on Reddit, Raises Price Target to $180

<p>The claims of the ‘856 patent and the ‘276 patent expand the range of protection for novel, non-obvious multi-substituent and halogenated psilocybin derivative compounds and pharmaceutical formulations containing such compounds, respectively.&nbsp;</p>


ENVB

Enveric Biosciences Announced That The United States Patent And Trademark Office Has Issued Two US Patents Bringing The Total Number Of Issued Patents Supporting Its EVM301 Series Molecules To 11

Johnson & Johnson Has Submitted Two Supplemental Biologics License Applications To The FDA Seeking Approval Of Tremfya (Guselkumab) For Children 6 Years And Older With Moderate-to-severe Plaque Psoriasis And Children 5 Years Of Age And Older With Active Juvenile Psoriatic Arthritis

<p>Leerink Partners  analyst Daniel Clark   initiates coverage on Elanco Animal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELAN#NYSE">ELAN</a>) with a Market Perform rating and announces Price Target of $14.</p>


ELAN

Leerink Partners Initiates Coverage On Elanco Animal Health with Market Perform Rating, Announces Price Target of $14

<p>Over the past five years, Northwest Healthcare has invested approximately $200 million in strategic growth and capital projects throughout the Greater Tucson Metro area, including two new hospitals – Northwest Medical Center Sahuarita and Northwest Medical Center Houghton. The Northwest Healthcare system provided medical care for more than 845,000 patient encounters in 2023.</p>


Northwest Urgent Care, A Tucson, Arizona, Subsidiary Of Community Health Systems Has Completed The Acquisition Of Certain Urgent Care Centers Owned And Operated By Carbon Health In Arizona

Reports Q3 revenue $22.5M, consensus $27.48M."We delivered a strong quarter of multi-year contract bookings valued up to $780 million, continuing t...

BlackSky reports Q3 EPS (66c), consensus (65c)

BlackSky (BKSY) is starting to ramp up revenues from recent contract awards and continues to work on a number of sizable new and expansion contract...

BlackSky sees FY24 revenue $102M- $118M, consensus $108.13M

In a report released today, Jeff Van Rhee from Craig-Hallum maintained a Buy rating on BlackSky Technology (BKSY – Research Report). The company's ...

BlackSky Technology (BKSY) Gets a Buy from Craig-Hallum

Blacksky Technology Inc. (BKSY) Q3 2024 Earnings Call Transcript

Blacksky Technology Inc. ( ($BKSY) ) has released its Q3 earnings. Here is a breakdown of the information Blacksky Technology Inc. presented to its...

BlackSky Technology Reports Q3 Growth and Strategic Wins

Oppenheimer analyst Timothy Horan maintained a Buy rating on BlackSky Technology (BKSY – Research Report) today and set a price target of $10.00. T...

Oppenheimer Reaffirms Their Buy Rating on BlackSky Technology (BKSY)

There's a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Ceva (CEVA – Research Report) and BlackSky Technolog...

Analysts Offer Insights on Technology Companies: Ceva (CEVA) and BlackSky Technology (BKSY)

BlackSky (BKSY) is up 21.2%, or $1.57 to $8.97. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial new...

BlackSky rises 21.2%

BlackSky: Next-Gen Satellites Bring Opportunities And Risks

BlackSky (BKSY) is up 5.9%, or 65c to $11.60. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news....

BlackSky rises 5.9%

CEVA

Press Releases

BlackSky Announces Pricing of Upsized $40 Million Public Offering of Common Stock

Penny Stocks

BlackSky Wins U.S. Navy Research Contract for Gen-3 Advanced Optical Intersatellite Links

BlackSky Announces Closing of Public Offering of Common Stock

BlackSky Wins Approximately $6 Million Contract Expansion with Legacy International Defense Sector Customer for Assured, High-Frequency Satellite Imagery Services

BlackSky Wins Five-Year NGA Luno A Contract Valued Up to $290 Million to Monitor Global Economic Activity and Military Capability

BlackSky Wins Seven-Figure Contract for Advanced Space Domain Awareness Solutions

BlackSky to Host Third Quarter 2024 Results Conference Call

LeoStella and BlackSky Selected for Space Development Agency Hybrid Acquisition for Proliferated Low-Earth Orbit program

BlackSky Reports Third Quarter 2024 Results

BlackSky to Participate at Three Upcoming Investor Conferences

Aeries Technology, Inc. - Class A Ordinary Share

Aeries Technology

Amentum Holdings

Clarivate

CRA Intl

Sunrise New Energy Co., Ltd - Class A Ordinary Shares

Sunrise New Energy

Falcon's Beyond Global, Inc. - Class A Common Stock

Falcons Beyond Global

Franklin Covey

Forrester Res

Graphex Group Limited American Depositary Shares, each American Depositary Share representing 20 Ordinary Shares

Graphex Gr

Huron Consulting Group Inc. - Common Stock

Huron Consulting Gr

ICF International

Innodata

Lichen China Limited - Class A Ordinary Shares

Lichen China

LegalZoom.com

MISTRAS Group

FiscalNote Holdings, Inc. Class A common stock

FiscalNote Holdings

NV5 Global

Planet Labs

RCM Technologies

Resources Connection, Inc. - Common Stock

Resources Connection

SOS Limited American Depositary Shares, one hundred and fifty (150) Class A Ordinary Shares

Comments

BlackSky Technology

Vendite allo scoperto

BlackSky Technology (NYSE:BKSY) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO